There are a couple of things, one around lung disease and the other around neurological diseases, and $15 million over four years for a study on neurological diseases, really to get some important baseline data, understanding of prevalence, risk factors, use of health services, economic costs, and really to get a more comprehensive understanding of neurological diseases, their impact, risk, and how you might actually intervene. That will set the stage, then, for future work moving forward.
On December 2nd, 2009. See this statement in context.